Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2012
11/29/2012US20120302587 Rho-kinase inhibitors
11/29/2012US20120302584 Novel salts forms of pyrimidin-5-yl acetic acid derivative
11/29/2012US20120302557 Biologically active methylene blue derivatives
11/29/2012US20120302539 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/29/2012US20120302537 Treatment methods using pharmaceutical solid state forms
11/29/2012US20120301551 Compounds and compositions for treating neuronal death or neurological dysfunction
11/29/2012US20120301486 Compositions and methods for inhibition of the jak pathway
11/29/2012US20120301478 Pharmaceutical for Preventing or Treating Disorders Accompanied by Ocular Angiogenesis and/or Elevated Ocular Vascular Permeability
11/29/2012US20120301472 Reagents and treatment methods for autoimmune diseases
11/29/2012US20120301464 Janus kinase inhibitors for treatment of dry eye and other eye related diseases
11/29/2012US20120301439 Inhibition of choroidal neovascularization
11/29/2012US20120301431 Methods of treating a disease or condition associated with abnormal angiogenesis
11/29/2012CA2836800A1 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/29/2012CA2835816A1 Novel metalloprotein and process for producing same, and prophylactic or therapeutic agent for corneal and conjunctival diseases comprising said metalloprotein
11/29/2012CA2832605A1 Pyridine-and pyrazine derivatives
11/29/2012CA2831161A1 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
11/28/2012EP2527443A2 RNAi-mediated inhibition of IGF-1R for treatment of ocular angiogenesis
11/28/2012EP2527355A2 Polymorphic and amorphous salt forms of squalamine dilactate
11/28/2012EP2527326A1 Novel compounds having 4-pyridylalkylthio group as substituent
11/28/2012EP2526948A1 RHO kinase inhibitors
11/28/2012EP2526923A1 Ophthalmic gel of gatifloxacin and preparation method thereof
11/28/2012EP2526094A1 Therapeutic substituted chlorocyclopentanols
11/28/2012EP2525794A1 5-(1h-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eye
11/28/2012EP2525793A2 Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect
11/28/2012CN1997394B Compositions and methods comprising an EGFL7 antagonist for modulating vascular development
11/28/2012CN102802654A Vaccine therapy for choroidal neovascularization
11/28/2012CN102802633A Method for improving bioavailability of latanoprost
11/28/2012CN102802619A Ophthalmic composition
11/28/2012CN102796741A Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
11/28/2012CN102796179A Template - fixed peptidomimetics with antimicrobial activity
11/28/2012CN102796161A Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
11/28/2012CN102796160A 17ss-hsd1 and sts inhibitors
11/28/2012CN102796095A Tetrahydroquinoline analogues as muscarinic agonists
11/28/2012CN102793911A Application of recombinant human Prx-6 protein to treatment of corneal injury
11/28/2012CN102793848A Traditional Chinese medicine powder for treating night blindness
11/28/2012CN102793786A Eye drops capable of preventing asthenopia
11/28/2012CN102793712A Application of chrysin in preparation of medicaments for treating autoimmune and inflammatory diseases
11/28/2012CN102793693A Applications of vorinostat in aspect of drugs for treating autoimmune diseases and inflammatory diseases
11/28/2012CN102793692A Compounds for inflammation and immune-related uses
11/28/2012CN102793690A Application of juglone to preparation of medicament for treating autoimmune and inflammatory diseases
11/28/2012CN102793672A Chitosan-modified methazolamide solid lipid nanoparticles and preparation method thereof
11/28/2012CN102319400B Traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and preparation method thereof
11/28/2012CN102319398B Blood-nourishing and eyesight-improving Chinese medicinal composition and preparation method thereof
11/28/2012CN102046170B Methods of treating mammals with eustachian tube dysfunctions
11/28/2012CN102002048B Water-soluble anionic bacteriochlorophyll derivatives and their uses
11/28/2012CN102002045B Pyrazolopyrimidinone derivatives as well as preparation method and application thereof
11/28/2012CN101812122B Protection effect of light-harvesting chromoprotein of algae on lens epithelial cells
11/28/2012CN101460176B Ocular allergy treatments
11/28/2012CN101107225B 12-aryl prostaglandin analogs
11/27/2012US8318769 Substituted sulfonamide compounds
11/27/2012US8318750 Organic compounds
11/27/2012US8318709 Combination of azelastine and mometasone for nasal administration
11/27/2012US8318689 SiRNA-based cancer treatment
11/27/2012US8318171 Neurotoxic oligomers
11/27/2012US8318169 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
11/27/2012CA2493122C Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
11/22/2012WO2012159064A1 High concentration olopatadine ophthalmic composition
11/22/2012WO2012158591A1 Anti-blepharitis products and methods
11/22/2012WO2012157790A1 Composition containing ginseng berry extract for activating mitochondria
11/22/2012WO2012157721A1 Liposome containing pyrroloquinoline quinone and sugar
11/22/2012WO2012157479A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
11/22/2012WO2012156600A1 Bixa orellana composition for treating macular degeneration
11/22/2012WO2012156225A1 Use of a sulfurated compound for the treatment of hyper-homocysteinemia.
11/22/2012US20120296088 Synthesis of udp-glucose: n-acylsphingosine glucosyl transferase inhibitors
11/22/2012US20120295979 Use of sulindac for protecting retinal pigment epithelial cells against oxidative stress
11/22/2012US20120295968 Pharmaceutical Composition Comprising Cannabinoids
11/22/2012US20120295967 High concentration olopatadine ophthalmic composition
11/22/2012US20120295953 Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
11/22/2012US20120295919 Arylpiperazine opioid receptor antagonists
11/22/2012US20120295909 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application
11/22/2012US20120295895 Compounds and methods of treating ocular disorders
11/22/2012US20120295889 3-Arylamino Pyridine Derivatives
11/22/2012US20120295884 Complement pathway modulators and uses thereof
11/22/2012US20120295869 Sterile Hyaluronic Acid Solutions
11/22/2012US20120295845 Imidazo-pyrazoles as gpr119 inhibitors
11/22/2012US20120295835 Sgef controls macular, corpus callosum and hippocampal function and development, liver homeostasis, functions of the immune system, fever response atherosclerosis and tumorogenic cell growth
11/22/2012US20120294895 Protein a compositions and methods of use
11/22/2012US20120294864 Endoglin Antibodies
11/22/2012US20120294849 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
11/22/2012US20120294838 Regulation of endogenous gene expression in cells using zinc finger proteins
11/22/2012US20120294834 Regeneration of, reestablishing function in and replacing microvasculature in organs and tissues
11/22/2012US20120294827 Polymer gel formulation
11/22/2012US20120294802 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/22/2012CA2835215A1 Compositions and methods for treating retinal diseases
11/22/2012CA2826725A1 High concentration olopatadine ophthalmic composition
11/21/2012EP2524693A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
11/21/2012EP2523953A1 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors
11/21/2012EP2523669A1 Combination, kit and method of reducing intraocular pressure
11/21/2012EP2523556A1 Methods of treating meibomian gland dysfunction
11/21/2012CN102791283A Use of transforming growth factor-beta 1 (TGF-beta 1) inhibitor peptides for the treatment of corneal fibrosis and/or haze
11/21/2012CN102791270A Methods and compositions for applying moxifloxacin to the ear
11/21/2012CN102787109A Methoxy polyethylene glycol-lumbrukinase conjugate and its preparation method
11/21/2012CN102786493A 2,3-diaryl thiazolidinone compound and analogue, and purpose thereof in preparing antiangiogenic drugs
11/21/2012CN102786464A Ftibamzone derivative and preparation method and application thereof
11/21/2012CN102786414A Compound for treating and/or preventing neurodegenerative related disease
11/21/2012CN102784381A Clinical scientific prescription for treating cataract
11/21/2012CN102784350A Mite killing bactericide and preparation method of mite killing bactericide
11/21/2012CN102784316A Cancer inhibition and flesh engendering medicine for treating burns, scalds, internal and external ulcer and cataract, and its preparation method
11/21/2012CN102784309A Drug for treating vertigo, and preparation method thereof
11/21/2012CN102784301A Traditional Chinese medicine treating early cataract and its preparation method
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 531